Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Omnicell (OMCL) Shares Outstanding (2016 - 2026)

Omnicell has reported Shares Outstanding over the past 16 years, most recently at $45.0 million for Q4 2025.

  • Quarterly Shares Outstanding fell 20.54% to $45.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $45.0 million through Dec 2025, down 20.54% year-over-year, with the annual reading at $45.0 million for FY2025, 20.54% down from the prior year.
  • Shares Outstanding was $45.0 million for Q4 2025 at Omnicell, roughly flat from $44.9 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $57.2 million in Q2 2025 and troughed at $44.9 million in Q3 2025.
  • The 5-year median for Shares Outstanding is $55.0 million (2022), against an average of $53.8 million.
  • Year-over-year, Shares Outstanding grew 3.06% in 2021 and then fell 20.71% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $54.1 million in 2021, then increased by 1.77% to $55.0 million in 2022, then increased by 1.44% to $55.8 million in 2023, then increased by 1.51% to $56.7 million in 2024, then decreased by 20.54% to $45.0 million in 2025.
  • Per Business Quant, the three most recent readings for OMCL's Shares Outstanding are $45.0 million (Q4 2025), $44.9 million (Q3 2025), and $57.2 million (Q2 2025).